Following HHS secretary Robert F. Kennedy Jr.’s decision last week to purge the CDC’s Advisory Committee on Immunization ...

June, advertising agencies that work behind the scenes to execute drug ads are rewarded with their moment in the spotlight as ...

The biopharma industry has hit a setback in its ambition to leverage President Donald Trump’s “big, beautiful bill” to amend ...

With the FDA's approval of hereditary angioedema preventative treatment Andembry, CSL is ready to take on Takeda’s ...

Trump has threatened that pharmaceutical import tariffs could clock in at “25% or higher.” The President first floated the ...

With Viatris taking home the biggest prize at this year’s Cannes Pharma Lions award and Biogen winning Gold, pharma is making ...

Four U.S. senators have reintroduced a bipartisan bill focused on strengthening the pharmaceutical supply chain by ...

Amid a spate of high-profile investments in U.S. pharmaceutical production, two contract manufacturers are getting in on the ...

Roche and AbbVie have once again come up short in their attempt to gain an additional indication for their blockbuster blood ...

European marketers are feeling the squeeze, with a combination of shrinking budgets, rising targets and tightening compliance requirements piling on the pressure, ...

Founder and Global CEO of Doceree, returns with Season 2 of “The Next Marketing with HJ”—a one-of-a-kind, knowledge-packed ...

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...